Health Canada has approved updated COVID-19 vaccines from Moderna and Pfizer-BioNTech for use in the upcoming 2025-2026 season. Moderna's new vaccine specifically targets the SARS-CoV-2 variant LP.8.1. This approval marks the first time that Moderna's COVID-19 vaccines will be manufactured in Canada, with doses expected to be available this fall. Infectious disease experts emphasize that these updated vaccines are an important tool to protect vulnerable populations from severe illness as the virus continues to circulate. Public health officials encourage individuals to stay current with vaccinations during this season, noting that vaccine availability may be limited in the future.